Trial Details

TERMINATED
Basic Information
Clinical ID c4395
Identifier NCT00584740
Trial Title Efficacy, Safety and Tolerability of AIN457 in Moderate to Severe Active Crohn's Disease
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Crohn's Disease
Interventions DRUG: AIN457|DRUG: Placebo
Participant Information
Sponsor Novartis Pharmaceuticals
City Berlin
Country/Region Germany
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2008-08
Primary Completion Date 2010-08
Completion Date 2010-08